Minister Han Seung-sook: Building an Entrepreneurial Ecosystem to Maximize SME Exports Minister Han Seung-sook of the Ministry of Small and Medium Enterprises and Startups held a press conference to commemorate the first anniversary of the government, reflecting on the achievements in small business and venture policies over the past year and outlining future priorities. She highlighted significant progress in promoting entrepreneurship while identifying the need for policy innovation in response to external crises as a key ongoing challenge. During the press conference on May 28, 2026

ABL Bio Begins Phase 1 Clinical Trials for Dual Antibody ADC in the U.S. ABL Bio announced on May 28 that Neok Bio has completed the first patient dosing in its Phase 1 clinical trials for the dual antibody drug conjugate (ADC) candidates ABL206 (NEOK001) and ABL209 (NEOK002) in the United States. Neok Bio is a U.S.-based biotechnology company established by ABL Bio, responsible for the global development and commercialization of these candidates. The dual antibody ADC technology targets two antigens simultaneously, delivering a chemical payload to cancer cell May 28, 2026

Samjin Pharmaceutical Expands CNS Business to Capture Aging Market Samjin Pharmaceutical is accelerating its expansion into the central nervous system (CNS) market, focusing on treatments for dementia and epilepsy. The company aims to develop this sector as a key growth area in response to the rapidly increasing demand driven by an aging population, building on its existing cardiovascular treatment business. According to market research firm IQVIA, the global CNS market is projected to grow from $154 billion in 2024 to $185 billion by 2029. The rise in t May 28, 2026

Boryung Expands Combination Drug Lineup with Launch of 'Canabjet' for Hypertension and Dyslipidemia Boryung announced it will launch 'Canabjet,' a treatment for hypertension and dyslipidemia, on June 1. Canabjet is a three-in-one combination drug that combines the angiotensin II receptor blocker (ARB) 'Canab' (active ingredient: Pimasartan) with the HMG-CoA reductase inhibitor 'Atorvastatin' and the cholesterol absorption inhibitor 'Ezetimibe.' It is intended for patients suffering from both hypertension and dyslipidemia, as well as high-risk patients who have not reached their LDL May 28, 2026

Binggrae's Third-Generation Owners Divide Roles Following Haitai Ice Cream Merger Binggrae is formalizing its third-generation ownership structure following the merger with Haitai Ice Cream. Dongman Kim, the second son of Chairman Ho-yeon Kim, has recently taken on the role of overseeing international operations, further clarifying the management roles between him and his older brother, Dong-hwan Kim. Industry experts are closely watching how the newly merged entity performs and whether it can expand its global business, as these factors may serve as key indicators May 28, 2026

Unification Minister Jeong Dong-young Denies Reports of Prosecutorial Investigation Unification Minister Jeong Dong-young has clarified that he has not received any notifications from relevant agencies regarding reports that he is under investigation by prosecutors for allegedly leaking information related to North Korean nuclear facilities. On May 28, the Unification Ministry's spokesperson issued a statement addressing media reports concerning the minister. The spokesperson stated, "The allocation of the case by the prosecution is merely a procedural measure followi May 28, 2026

LG Energy Solution Shares Surge After Major ESS Contract with DTE Energy LG Energy Solution's shares rose more than 15% following the announcement of a supply contract for energy storage systems (ESS) worth approximately 2 trillion won with a major U.S. energy company. Market expectations are growing that the increasing power demand from artificial intelligence (AI) data centers will serve as a new growth driver for the domestic battery sector. According to the Korea Exchange, LG Energy Solution's stock closed at 442,000 won, up 58,500 won (15.25%) from the pr May 28, 2026

Samsung Electronics Falls While SK Hynix Rises as Leverage ETFs Attract $9.6 Billion After a strong debut, the single-stock leverage ETFs for Samsung Electronics and SK Hynix showed diverging trends. While the SK Hynix leverage ETF continued to gain, the Samsung Electronics leverage ETF experienced a decline. According to the Korea Exchange, Samsung Electronics closed at 299,500 won, down 7,500 won (2.44%) from the previous trading day, while SK Hynix rose by 46,000 won (2.05%) to finish at 2,289,000 won. Consequently, the performance of the leverage ETFs tracking these May 28, 2026

Prosecutors Cancel Charges Against Victim of 43-Year-Old Spy Case Prosecutors have canceled the suspended charges against Kim Byung-jin, a 71-year-old victim of a fabricated spy ring case involving the Military Security Command, 43 years after the initial charges were filed. This marks the first instance of prosecutors taking action to relieve a victim of suspended charges on their own authority. The Seoul Central District Prosecutors' Office announced on May 28 that it had reinstated Kim's case, which had been suspended due to violations of the Nation May 28, 2026

Samsung Electronics Faces Employee Discontent Over Performance Bonuses Samsung Electronics is facing escalating discontent among employees in its Device Experience (DX) division regarding performance bonuses. Despite an official apology from DX head Noh Tae-moon, discussions about a potential spin-off have emerged as tensions remain high.On May 28, an anonymous post on a Samsung Electronics community called for the formal establishment of a committee to pursue the spin-off of the DX division, attracting significant attention. More than 1,100 employees have particip May 28, 2026